Integrin-binding peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5627263
SERIAL NO

08425238

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides peptides having specificity for fibronectin-binding and vitronectin-binding integrins, and in particular for .alpha..sub.5 .beta..sub.1 integrin. These peptides are characterized by having the ability to interfere with fibronectin binding to .alpha..sub.5 .beta..sub.1 integrin, to block attachment of cells expressing integrins to extracellular matrix proteins and to promote cell attachment when immobilized onto a surface.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LA JOLLA CANCER RESEARCH FOUNDATIONLA JOLLA CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Koivunen, Erkki San Diego, CA 20 648
Ruoslahti, Erkki Rancho Santa Fe, CA 118 2392

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation